Literature DB >> 11885822

Comparison of the smoking behaviour and attitudes of smokers who attribute respiratory symptoms to smoking with those who do not.

Nikki Walters1, Tim Coleman.   

Abstract

General practitioners' (GPs') advice against smoking helps smokers to stop; unfortunately, GPs cannot predict which patients will quit following advice. This postal questionnaire survey suggests that where smokers attribute their respiratory symptoms to smoking, they are eight times (95% confidence interval [CI] = 3.0-23.3) more likely to believe that their health will improve if they stop smoking and six times (95% CI = 1.4-23.3) more likely to intend to stop smoking.

Entities:  

Mesh:

Year:  2002        PMID: 11885822      PMCID: PMC1314219     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  3 in total

1.  A cross-sectional study comparing the motivation for smoking cessation in apparently healthy patients who smoke to those who smoke and have ischaemic heart disease, hypertension or diabetes.

Authors:  S Wilkes; A Evans
Journal:  Fam Pract       Date:  1999-12       Impact factor: 2.267

2.  A comparison of individual and population smoking data from a postal survey and general practice records.

Authors:  A Wilson; T Manku-Scott; D Shepherd; B Jones
Journal:  Br J Gen Pract       Date:  2000-06       Impact factor: 5.386

3.  Age and the role of symptomatology in readiness to quit smoking.

Authors:  M A Clark; J W Hogan; F J Kviz; T R Prohaska
Journal:  Addict Behav       Date:  1999 Jan-Feb       Impact factor: 3.913

  3 in total
  8 in total

1.  Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years.

Authors:  Georgios Stratelis; Per Jakobsson; Siguard Molstad; Olle Zetterstrom
Journal:  Br J Gen Pract       Date:  2004-03       Impact factor: 5.386

2.  Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention.

Authors:  Stefan Andreas; Thomas Hering; Stephan Mühlig; Dennis Nowak; Tobias Raupach; Heinrich Worth
Journal:  Dtsch Arztebl Int       Date:  2009-04-17       Impact factor: 5.594

Review 3.  Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.

Authors:  Edwin J Wagena; Maurice P A Zeegers; Constant P van Schayck; Emiel F M Wouters
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

4.  Awareness of blindness and other smoking-related diseases and its impact on motivation for smoking cessation in eye patients.

Authors:  S Handa; J H Woo; A M Wagle; H M Htoon; K G Au Eong
Journal:  Eye (Lond)       Date:  2011-06-24       Impact factor: 3.775

5.  Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series.

Authors:  Pasquale Caponnetto; Riccardo Polosa; Cristina Russo; Carmelo Leotta; Davide Campagna
Journal:  J Med Case Rep       Date:  2011-12-20

6.  'To use or not to use': a qualitative study to evaluate experiences of healthcare providers and patients with the assessment of burden of COPD (ABC) tool.

Authors:  Annerika H M Slok; Mascha Twellaar; Leslie Jutbo; Daniel Kotz; Niels H Chavannes; Sebastiaan Holverda; Philippe L Salomé; P N Richard Dekhuijzen; Maureen P M H Rutten-van Mölken; Denise Schuiten; Johannes C C M In 't Veen; Onno C P van Schayck
Journal:  NPJ Prim Care Respir Med       Date:  2016-11-17       Impact factor: 2.871

7.  Risk Factors for the Absence of Diagnosis of Asthma Despite Disease Symptoms: Results from the Swedish GA2LEN Study.

Authors:  Marta A Kisiel; Martin Jacobsson; Susann Järhult; Linda Ekerljung; Kjell Alving; Roelinde Middelveld; Karl Franklin; Christer Janson
Journal:  J Asthma Allergy       Date:  2022-02-09

8.  A cross-sectional survey investigating the desensitisation of graphic health warning labels and their impact on smokers, non-smokers and patients with COPD in a London cohort.

Authors:  Culadeeban Ratneswaran; Ben Chisnall; Panagis Drakatos; Sukhanthan Sivakumar; Bairavie Sivakumar; Miriam Barrecheguren; Abdel Douiri; Joerg Steier
Journal:  BMJ Open       Date:  2014-07-04       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.